- Home
- COEP
as 04-01-2025 3:34pm EST
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | WEXFORD |
| Market Cap: | 30.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 41.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.31 - $13.70 | Next Earning Date: | 05-09-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Coeptis Therapeutics Holdings Inc. News
COEP Breaking Stock News: Dive into COEP Ticker-Specific Updates for Smart Investing
GlobeNewswire
22 days ago
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
GlobeNewswire
25 days ago
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
GlobeNewswire
a month ago
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Insider Monkey
2 months ago
Coeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel Innovation
GlobeNewswire
2 months ago
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups
Insider Monkey
2 months ago
Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations
PR Newswire
2 months ago
COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
Insider Monkey
2 months ago
Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation
Compare COEP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "COEP Coeptis Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.